E&G Advisors’s Gilead Sciences GILD Stock Holding History

E&G Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.1M	Buy	16,647 +324	+2%	+$42.7K	0.41%	46
2026 Q1	$2.27M	Sell	16,323 -66	-0.4%	-$9.24K	0.51%	37
2025 Q4	$2.01M	Sell	16,389 -200	-1%	-$24.3K	0.45%	39
2025 Q3	$1.84M	Buy	16,589 +7	+0%	+$796	0.43%	43
2025 Q2	$1.84M	Sell	16,582 -821	-5%	-$87.4K	0.48%	38
2025 Q1	$1.95M	Sell	17,403 -26	-0.1%	-$2.68K	0.55%	34
2024 Q4	$1.61M	Sell	17,429 -400	-2%	-$36K	0.44%	43
2024 Q3	$1.49M	Hold	17,829	–	–	0.41%	52
2024 Q2	$1.22M	Hold	17,829	–	–	0.36%	62
2024 Q1	$1.31M	Hold	17,829	–	–	0.41%	55
2023 Q4	$1.44M	Sell	17,829 -900	-5%	-$70K	0.51%	43
2023 Q3	$1.4M	Sell	18,729 -360	-2%	-$27.7K	0.51%	47
2023 Q2	$1.47M	Hold	19,089	–	–	0.51%	43
2023 Q1	$1.58M	Sell	19,089 -420	-2%	-$34.8K	0.59%	36
2022 Q4	$1.67M	Sell	19,509 -1,600	-8%	-$127K	0.63%	34
2022 Q3	$1.3M	Sell	21,109 -600	-3%	-$37.8K	0.48%	45
2022 Q2	$1.34M	Hold	21,709	–	–	0.45%	47
2022 Q1	$1.29M	Buy	21,709 +300	+1%	+$19.2K	0.35%	66
2021 Q4	$1.55M	Hold	21,409	–	–	0.39%	56
2021 Q3	$1.5M	Buy	+21,409	New	+$1.5M	0.41%	54
2021 Q2	–	Sell	-21,309	Closed	-$1.42M	–	54
2021 Q1	$1.38M	Sell	21,309 -374	-2%	-$24.1K	0.4%	52
2020 Q4	$1.26M	Buy	21,683 +300	+1%	+$18.1K	0.39%	55
2020 Q3	$1.35M	Sell	21,383 -1,852	-8%	-$128K	0.47%	45
2020 Q2	$1.79M	Hold	23,235	–	–	0.69%	24
2020 Q1	$1.74M	Sell	23,235 -1,600	-6%	-$111K	0.86%	19
2019 Q4	$1.61M	Hold	24,835	–	–	0.6%	38
2019 Q3	$1.57M	Sell	24,835 -597	-2%	-$39K	0.63%	40
2019 Q2	$1.72M	Sell	25,432 -997	-4%	-$65.6K	0.73%	31
2019 Q1	$1.72M	Sell	26,429 -2,597	-9%	-$173K	0.76%	28
2018 Q4	$1.82M	Buy	29,026 +603	+2%	+$42.1K	0.82%	24
2018 Q3	$2.19M	Buy	28,423 +1,221	+4%	+$92.2K	0.83%	23
2018 Q2	$1.93M	Sell	27,202 -60	-0.2%	-$4.24K	0.81%	24
2018 Q1	$2.06M	Buy	27,262 +1,165	+4%	+$92.6K	0.88%	21
2017 Q4	$1.87M	Sell	26,097 -1,298	-5%	-$98.6K	0.79%	24
2017 Q3	$2.22M	Sell	27,395 -99	-0.4%	-$7.57K	1%	19
2017 Q2	$1.95M	Buy	27,494 +1,800	+7%	+$120K	0.94%	26
2017 Q1	$1.75M	Buy	25,694 +99	+0.4%	+$6.96K	0.9%	26
2016 Q4	$1.83M	Sell	25,595 -2,446	-9%	-$182K	1.09%	18
2016 Q3	$2.22M	Sell	28,041 -1,100	-4%	-$89.4K	1.3%	14
2016 Q2	$2.43M	Sell	29,141 -4,652	-14%	-$413K	1.48%	13
2016 Q1	$3.1M	Sell	33,793 -5,340	-14%	-$482K	2.02%	11
2015 Q4	$3.96M	Sell	39,133 -8,046	-17%	-$837K	2.37%	12
2015 Q3	$4.63M	Buy	47,179 +500	+1%	+$55.5K	2.95%	7
2015 Q2	$5.46M	Sell	46,679 -200	-0.4%	-$21.9K	3.19%	6
2015 Q1	$4.6M	Buy	46,879 +1,710	+4%	+$174K	2.71%	8
2014 Q4	$4.26M	Sell	45,169 -1,900	-4%	-$197K	2.76%	6
2014 Q3	$5.01M	Sell	47,069 -219	-0.5%	-$21.4K	3.22%	4
2014 Q2	$3.92M	Sell	47,288 -2,920	-6%	-$227K	2.53%	7
2014 Q1	$3.56M	Buy	50,208 +3,410	+7%	+$267K	2.8%	4
2013 Q4	$3.52M	Buy	+46,798	New	+$3.26M	3.29%	3

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

E&G Advisors's GILD Position: Q2 2026 in Review

E&G Advisors increased its Gilead Sciences (GILD) stake by 2% in Q2 2026, buying an estimated $42.7K and bringing the position to 16,647 shares worth $2.1M. The position accounts for 0.41% of the portfolio, ranked #46.

E&G Advisors first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. The position peaked at $5.46M in Q2 2015. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

E&G Advisors held 16,647 shares of Gilead Sciences worth $2.1M as of Q2 2026.
E&G Advisors bought 324 Gilead Sciences shares in Q2 2026, an estimated $42.7K.
Gilead Sciences made up 0.41% of E&G Advisors's portfolio in Q2 2026, its #46 holding.
E&G Advisors first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
E&G Advisors's Gilead Sciences position peaked at $5.46M in Q2 2015.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on E&G Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.